This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bennett, T. N.
Right arrow Articles by Roepe, P. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bennett, T. N.
Right arrow Articles by Roepe, P. D.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, May 2004, p. 1807-1810, Vol. 48, No. 5
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.5.1807-1810.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Novel, Rapid, and Inexpensive Cell-Based Quantification of Antimalarial Drug Efficacy

Tyler N. Bennett, Michelle Paguio, Bojana Gligorijevic, Clement Seudieu, Andrew D. Kosar, Eugene Davidson, and Paul D. Roepe*

Department of Chemistry, Department of Biochemistry and Molecular Biology, and Lombardi Cancer Center, Georgetown University, Washington DC 20057

Received 2 September 2003/ Returned for modification 27 October 2003/ Accepted 12 January 2004

We report on the development of a new SYBR Green I-based plate assay for analyzing the activities of antimalarial drugs against intraerythrocytic Plasmodium falciparum. This assay is considerably faster, less labor-intensive, and less expensive than conventional radiotracer (e.g., [3H]hypoxanthine and [3H]ethanolamine)-based assays or P. falciparum lactate dehydrogenase activity-based assays. The assay significantly improves the pace at which antimalarial drug discovery efforts may proceed.


* Corresponding author. Mailing address: Department of Chemistry, Georgetown University, 37th and O St. NW, Washington, DC 20057. Phone: (202) 687-7300. Fax: (202) 687-6209. E-mail roepep{at}georgetown.edu.


Antimicrobial Agents and Chemotherapy, May 2004, p. 1807-1810, Vol. 48, No. 5
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.5.1807-1810.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • van Schalkwyk, D. A., Priebe, W., Saliba, K. J. (2008). The Inhibitory Effect of 2-Halo Derivatives of D-Glucose on Glycolysis and on the Proliferation of the Human Malaria Parasite Plasmodium falciparum. J. Pharmacol. Exp. Ther. 327: 511-517 [Abstract] [Full Text]  
  • Liu, S., Mu, J., Jiang, H., Su, X.-z. (2008). Effects of Plasmodium falciparum Mixed Infections on In Vitro Antimalarial Drug Tests and Genotyping. Am J Trop Med Hyg 79: 178-184 [Abstract] [Full Text]  
  • Plouffe, D., Brinker, A., McNamara, C., Henson, K., Kato, N., Kuhen, K., Nagle, A., Adrian, F., Matzen, J. T., Anderson, P., Nam, T.-g., Gray, N. S., Chatterjee, A., Janes, J., Yan, S. F., Trager, R., Caldwell, J. S., Schultz, P. G., Zhou, Y., Winzeler, E. A. (2008). From the Cover: In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen. Proc. Natl. Acad. Sci. USA 105: 9059-9064 [Abstract] [Full Text]  
  • Johnson, J. D., Dennull, R. A., Gerena, L., Lopez-Sanchez, M., Roncal, N. E., Waters, N. C. (2007). Assessment and Continued Validation of the Malaria SYBR Green I-Based Fluorescence Assay for Use in Malaria Drug Screening. Antimicrob. Agents Chemother. 51: 1926-1933 [Abstract] [Full Text]  
  • Bacon, D. J., Latour, C., Lucas, C., Colina, O., Ringwald, P., Picot, S. (2007). Comparison of a SYBR Green I-Based Assay with a Histidine-Rich Protein II Enzyme-Linked Immunosorbent Assay for In Vitro Antimalarial Drug Efficacy Testing and Application to Clinical Isolates. Antimicrob. Agents Chemother. 51: 1172-1178 [Abstract] [Full Text]